Peptide profile
Thymulin
Thymus peptide for immune modulation
Compare Thymulin with other peptides →Summary
A tiny protein from the thymus gland. It helps keep your immune system balanced.
- Typical dose
- 0.5-1.0mg Daily or every other day
- Route
- Subcutaneous
- Cycle length
- 30-60 days
- Evidence
- Animal data
Mechanism
How it works
Thymulin acts like a training academy for immune cells — it educates young T-cells to distinguish self from invader.
Nonapeptide produced by thymic epithelial cells that induces T-cell differentiation and modulates cytokine production.
Reported in research
Benefits
- Helps young immune cells grow up and do their jobs
- Boosts your body's defenses when you are older or stressed
- Calms down swelling that lasts a long time
- May help vaccines work better
Context, not a prescription
Dosing
- Typical range
- 0.5-1.0mg Daily or every other day (Subcutaneous)
- Cycle length
- 30-60 days
Safety
Side effects & contraindications
Possible side effects
- Mild injection site pain
- Low-grade fever
- Temporary fatigue
- Allergic reaction
- Headache
- Nausea
Contraindications
- Active autoimmune disease flare
- Organ transplant recipients
- Pregnancy or breastfeeding
Research information, not medical advice. Always consult a licensed clinician before considering any peptide.
In depth
Full profile
What it does
A more balanced immune system, stronger immune cells, and fewer chances of getting sick.
How it works
Thymulin is like a school for immune cells. It teaches young cells to tell friends from invaders.
It connects to special spots on immune cells. It needs zinc to do its job.
What to expect
You may notice changes in your defenses within 2-3 weeks.
- Weeks 1-2: Your immune system starts to balance out.
- Weeks 3-4: Your immune cells become more active.
- Weeks 6-8: You get sick less often and have less swelling.
Good to know
- Start with a smaller dose (0.25mg)
- Watch for signs your body is attacking itself
- Take breaks between cycles
Staying safe
- A little pain where you got the shot
- A slight fever
- Feeling tired for a short time
Avoid if you have:
- People whose body is attacking itself right now
- People who got a new organ from a donor
- Pregnant or breastfeeding moms
Mechanism of action
Nonapeptide produced by thymic epithelial cells that induces T-cell differentiation and modulates cytokine production.
Binds to specific receptors on thymocytes and mature T-cells, requiring zinc for biological activity.
Pharmacodynamics
Immune effects within 2-3 weeks.
Improved immune balance, better T-cell function, reduced infection risk.
Timeline
- Weeks 1-2: Initial immune modulation.
- Weeks 3-4: Enhanced T-cell activity.
- Weeks 6-8: Reduced infection frequency and inflammation.
Comparisons
- Thymulin — effectiveness Moderate, safety Good, cost $$, Easy to use
- Thymosin Alpha-1 — effectiveness High, safety Excellent, cost $$, Easy to use
Adverse effects
Common:
- Mild injection site pain
- Low-grade fever
- Temporary fatigue
Rare:
- Allergic reaction
- Headache
- Nausea
Contraindications & risk mitigation
Contraindicated in:
- Active autoimmune disease flare
- Organ transplant recipients
- Pregnancy or breastfeeding
- Start with lower dose (0.25mg)
- Monitor for autoimmune symptoms
- Cycle with breaks
Qué hace
Un sistema inmune más equilibrado, células inmunes más fuertes y menos probabilidades de enfermarse.
Cómo funciona
Thymulin es como una escuela para las células inmunes. Enseña a las células jóvenes a distinguir a los amigos de los invasores.
Se conecta a puntos especiales en las células inmunes. Necesita zinc para realizar su función.
Qué esperar
Puedes notar cambios en tus defensas en 2-3 semanas.
- Semanas 1-2: Tu sistema inmune comienza a equilibrarse.
- Semanas 3-4: Tus células inmunes se vuelven más activas.
- Semanas 6-8: Te enfermas con menos frecuencia y tienes menos inflamación.
Bueno saber
- Comenzar con una dosis más pequeña (0.25 mg)
- Vigilar señales de que el cuerpo se está atacando a sí mismo
- Tomar descansos entre ciclos
Manteniéndose seguro
- Un poco de dolor en el lugar de la inyección
- Una fiebre leve
- Sentirse cansado por un corto tiempo
Evitar si tienes:
- Personas cuyo cuerpo se está atacando a sí mismo actualmente
- Personas que recibieron un nuevo órgano de un donante
- Madres embarazadas o en período de lactancia
Mecanismo de acción
Nonapéptido producido por células epiteliales del timo que induce la diferenciación de células T y modula la producción de citocinas.
Se une a receptores específicos en timocitos y células T maduras, requiriendo zinc para su actividad biológica.
Farmacodinamia
Efectos inmunes en 2-3 semanas.
Mejor equilibrio inmune, mejor función de células T, menor riesgo de infecciones.
Cronología
- Semanas 1-2: Modulación inmune inicial.
- Semanas 3-4: Actividad mejorada de células T.
- Semanas 6-8: Reducción en la frecuencia de infecciones e inflamación.
Comparaciones
- Thymulin — efectividad Moderada, seguridad Buena, costo $$, Fácil de usar
- Timosina alfa-1 — efectividad Alta, seguridad Excelente, costo $$, Fácil de usar
Efectos adversos
Comunes:
- Dolor leve en el sitio de inyección
- Fiebre baja
- Fatiga temporal
Raros:
- Reacción alérgica
- Dolor de cabeza
- Náuseas
Contraindicaciones y mitigación de riesgos
Contraindicado en:
- Crisis activa de enfermedad autoinmune
- Receptores de trasplante de órganos
- Embarazo o lactancia
- Comenzar con dosis menor (0.25 mg)
- Monitorear síntomas autoinmunes
- Ciclar con descansos
Reference data
Specifications
- Route
- Subcutaneous
- Cycle length
- 30-60 days
FAQ
Common questions
Does thymulin require zinc?
Yes, thymulin's biological activity is zinc-dependent. Ensure adequate zinc intake during use.
Is thymulin similar to thymosin alpha-1?
Both are thymus peptides, but thymulin targets T-cell maturation while thymosin alpha-1 enhances existing T-cell function.
What is the evidence level?
This compound is classified as Animal data. Most data comes from preclinical animal studies. Human clinical trial evidence is limited or absent.
Research
Research & sources
Current evidence for Thymulin is rated as Animal data. Research is based primarily on animal models.
- 1. Thymulin and immunity (1999) — DOI:10.1016/S0165-2478(99)00157-3
- 2. Thymic peptides review (2017) — DOI:10.1016/j.cyto.2017.07.020
- 3. Thymulin and immunity (1999)
- 4. Thymic peptides review (2017)